TY  - JOUR
AU  - Shah, Jatin
AU  - Shacham, Sharon
AU  - Kauffman, Michael
AU  - Daniele, Patrick
AU  - Tomaras, Dimitrios
AU  - Tremblay, Gabriel
AU  - Casasnovas, Rene-Olivier
AU  - Maerevoet, Marie
AU  - Zijlstra, Josee
AU  - Follows, George
AU  - P Vermaat, Joost S
AU  - Kalakonda, Nagesh
AU  - Goy, Andre Henri
AU  - Choquet, Sylvain
AU  - Den Neste, Eric Van
AU  - Hill, Brian T
AU  - Thieblemont, Catherine
AU  - Cavallo, Federica
AU  - la Cruz, Fátima de
AU  - Kuruvilla, John
AU  - Hamad, Nada
AU  - Bouabdallah, Reda
AU  - Jäger, Ulrich
AU  - Caimi, Paolo
AU  - Gurion, Ronit
AU  - Warzocha, Krzysztof
AU  - Bakhshi, Sameer
AU  - Sancho, Juan Manuel
AU  - Schuster, Michael
AU  - Egyed, Miklós
AU  - Offner, Fritz
AU  - Vasilakopoulos, Theodoros P
AU  - Samal, Priyanka
AU  - Nagy, Agnes
AU  - Ku, Matthew
AU  - Canales Albendea, Miguel Ángel
PY  - 2021
DO  - 10.2217/fon-2020-0946
UR  - http://hdl.handle.net/10668/17083
T2  - Future oncology (London, England)
AB  - Aim: Evaluate health-related quality of life (HRQoL) and health utility impact of single-agent selinexor in heavily pretreated patients with relapsed/refractory diffuse large B-cell lymphoma. Patients & methods: Functional Assessment of Cancer Therapy...
LA  - en
KW  - EQ-5D-5L
KW  - FACT-Lym
KW  - diffuse large B-cell lymphoma
KW  - disutility of adverse events
KW  - health state utility
KW  - health utility
KW  - health-related quality of life
KW  - patient-reported outcomes
KW  - selinexor
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Hydrazines
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - Male
KW  - Middle Aged
KW  - Patient Reported Outcome Measures
KW  - Quality of Life
KW  - Recurrence
KW  - Triazoles
TI  - Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma.
TY  - research article
VL  - 17
ER  -